Inventor · disambiguated record
Simon Dovedi
Also filed as: DOVEDI SIMON
4 granted patents·10 pending applications·18 citations·filing 2015–2025
74Inventor score
Top patents by PatentIndex Score
14 records- 0193US10457732B2Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2017·Granted Oct 29, 2019·10 cites·12 claims
- 0289USRE49908EBispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2021·Granted Apr 9, 2024·1 cites·43 claims
- 0389US11279759B2Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2019·Granted Mar 22, 2022·4 cites·19 claims
- 0487US2025074986A1Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2024·Application pending·0 cites
- 0575US2022251204A1Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2021·Application pending·0 cites
- 0674US10092645B2Methods of treatment with antagonists against PD-1 and PD-L1 in combination with radiation therapyMEDIMMUNE LTD·Filed 2015·Granted Oct 9, 2018·3 cites·17 claims
- 0765US2025115678A1T cell binding compositions and methodsASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0863US2022073622A1Compositions and Methods for Treating Late Stage Lung CancerASTRAZENECA AB·Filed 2021·Application pending·0 cites
- 0961US2025059295A1Steap2 directed t-cell engagers and compositions thereofMEDIMMUNE LLC·Filed 2024·Application pending·0 cites
- 1060US2025340648A1Combination therapy for treatment of cancer comprising anti-pd-l1 and anti-cd73 antibodiesMEDIMMUNE LTD·Filed 2023·Application pending·0 cites
- 1145US2019192655A1Methods of treatment with antagonists against pd-1 and pd-l1 in combination with radiation therapyMEDIMMUNE LTD·Filed 2018·Application pending·0 cites
- 1244US2019241659A1Bispecific fusion polypeptides and methods of use thereofMEDIMMUNE LLC·Filed 2018·Application pending·0 cites
- 1344US2019276543A1Compositions and methods for treating late stage lung cancerASTRAZENECA PHARMACEUTICALS LP·Filed 2018·Application pending·0 cites
- 1443US2025249093A1Cytokine engagers and uses thereofASTRAZENECA AB·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →